JP2009545620A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009545620A5 JP2009545620A5 JP2009523051A JP2009523051A JP2009545620A5 JP 2009545620 A5 JP2009545620 A5 JP 2009545620A5 JP 2009523051 A JP2009523051 A JP 2009523051A JP 2009523051 A JP2009523051 A JP 2009523051A JP 2009545620 A5 JP2009545620 A5 JP 2009545620A5
- Authority
- JP
- Japan
- Prior art keywords
- inhibitor
- pharmaceutically acceptable
- acceptable salt
- use according
- vla
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US83529006P | 2006-08-02 | 2006-08-02 | |
| PCT/US2007/075064 WO2008017025A2 (en) | 2006-08-02 | 2007-08-02 | Combination therapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009545620A JP2009545620A (ja) | 2009-12-24 |
| JP2009545620A5 true JP2009545620A5 (https=) | 2010-09-09 |
Family
ID=38997866
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009523051A Withdrawn JP2009545620A (ja) | 2006-08-02 | 2007-08-02 | 併用療法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20100003224A1 (https=) |
| EP (1) | EP2068868A2 (https=) |
| JP (1) | JP2009545620A (https=) |
| CN (1) | CN101495115A (https=) |
| AR (1) | AR063470A1 (https=) |
| AU (1) | AU2007281090A1 (https=) |
| BR (1) | BRPI0714799A2 (https=) |
| CA (1) | CA2659463A1 (https=) |
| IL (1) | IL196556A0 (https=) |
| MX (1) | MX2009001272A (https=) |
| RU (1) | RU2009107030A (https=) |
| WO (1) | WO2008017025A2 (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004020462A1 (ja) | 2002-08-27 | 2004-03-11 | Fujii, Nobutaka | Ｃｘｃｒ４拮抗薬およびその用途 |
| CA2673719C (en) * | 2006-12-21 | 2018-07-24 | Biokine Therapeutics Ltd. | T-140 peptide analogs having cxcr4 super-agonist activity for bone marrow recovery |
| US9427456B2 (en) | 2009-06-14 | 2016-08-30 | Biokine Therapeutics Ltd. | Peptide therapy for increasing platelet levels |
| WO2012034194A1 (en) * | 2010-09-17 | 2012-03-22 | Antisense Therapeutics Ltd | Method for mobilizing stem and/or progenitor cells |
| US9682078B2 (en) | 2011-03-18 | 2017-06-20 | University Of Virginia Patent Foundation | Compositions and methods for tissue engineering and cell based therapies |
| RU2638802C2 (ru) | 2011-05-16 | 2017-12-15 | Джензим Корпорейшн | Применение антагонистов cxcr4 |
| WO2012174522A1 (en) * | 2011-06-16 | 2012-12-20 | Children's Medical Center Corporation | Combined chemical modification of sphingosine-1-phosphate (s1p) and cxcr4 signalling pathways for hematopoietic stem cell (hsc) mobilization and engraftment |
| US9439942B2 (en) | 2012-04-24 | 2016-09-13 | Biokine Therapeutics Ltd. | Peptides and use thereof in the treatment of large cell lung cancer |
| SG11201704756YA (en) * | 2014-12-12 | 2017-07-28 | Commw Scient Ind Res Org | Dislodgement and release of hsc using alpha 9 integrin antagonist and cxcr4 antagonist |
| IL274572B2 (en) | 2015-07-16 | 2024-01-01 | Biolinerx Ltd | Compositions and methods for treating cancer |
| CN109310733A (zh) | 2016-02-23 | 2019-02-05 | 百欧林纳克斯有限公司 | 治疗急性骨髓性白血病的方法 |
| JP7034085B2 (ja) * | 2016-04-08 | 2022-03-11 | サイロス ファーマシューティカルズ， インコーポレイテッド | Ａｍｌ及びｍｄｓの治療のためのｒａｒａアゴニスト |
| WO2018085574A2 (en) * | 2016-11-02 | 2018-05-11 | Washington University | Compositions comprising an integrin inhibitor and agents which interact with a chemokine and methods of use thereof |
| TWI734027B (zh) * | 2017-09-18 | 2021-07-21 | 泰宗生物科技股份有限公司 | 用於治療癌症之組合物 |
| CN111712262A (zh) * | 2017-12-06 | 2020-09-25 | 美真达治疗公司 | 用于动员造血干细胞和祖细胞的给药方案 |
| US11260079B2 (en) | 2017-12-06 | 2022-03-01 | Magenta Therapeutics, Inc. | Dosing regimens for the mobilization of hematopoietic stem and progenitor cells |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5021409A (en) * | 1989-12-21 | 1991-06-04 | Johnson Matthey Plc | Antiviral cyclic polyamines |
| US6001826A (en) * | 1989-12-21 | 1999-12-14 | Anormed, Inc. | Chemical compounds |
| GB9126677D0 (en) * | 1991-12-16 | 1992-02-12 | Johnson Matthey Plc | Improvements in chemical compounds |
| DE69433301T2 (de) * | 1993-06-08 | 2004-09-09 | Smithkline Beecham Corp. | Methoden zur erhöhung der biologischen aktivität von chemokinen |
| US6447766B1 (en) * | 1993-06-08 | 2002-09-10 | Smithkline Beecham Corporation | Method of mobilizing hematopoietic stem cells |
| US5510332A (en) * | 1994-07-07 | 1996-04-23 | Texas Biotechnology Corporation | Process to inhibit binding of the integrin α4 62 1 to VCAM-1 or fibronectin and linear peptides therefor |
| ATE180843T1 (de) * | 1994-08-19 | 1999-06-15 | Akzo Nobel Nv | Zelluloselösungen und hieraus hergestellte produkte |
| US6506770B1 (en) * | 1996-06-06 | 2003-01-14 | Anormed, Inc. | Antiviral compounds |
| US5968546A (en) * | 1997-05-16 | 1999-10-19 | Baur; Marcus | Keratinocyte culture from precursor cells |
| HUP0102255A3 (en) * | 1998-05-28 | 2001-12-28 | Biogen Idec Ma Inc Cambridge | Vla-4 inhibitor omepupa-v, pharmaceutical compositions comprising thereof and their use |
| US6365583B1 (en) * | 1999-02-02 | 2002-04-02 | Anormed, Inc. | Methods to enhance white blood cell count |
| US6750348B1 (en) * | 1999-03-24 | 2004-06-15 | Anormed, Inc. | Chemokine receptor binding heterocyclic compounds |
| GEP20053477B (en) * | 1999-08-13 | 2005-03-25 | Biogen Inc | Cell Adhesion Inhibitors and Pharmaceutical Compositions Containing Them |
| DE60042030D1 (de) * | 1999-12-17 | 2009-05-28 | Genzyme Corp | Chemokinrezeptor-bindende heterocyclische verbindungen |
| US6835731B2 (en) * | 2000-09-15 | 2004-12-28 | Anormed, Inc. | Chemokine receptor binding heterocyclic compounds |
| PT1317451E (pt) * | 2000-09-15 | 2006-12-29 | Anormed Inc | Compostos heterocíclicos que se ligam a receptores de quimioquinas |
| CA2419224A1 (en) * | 2000-09-15 | 2002-03-21 | Anormed Inc. | Chemokine receptor binding heterocyclic compounds |
| AU2002211393B2 (en) * | 2000-09-29 | 2007-06-28 | Anormed Inc. | Process for preparation of n-1 protected n ring nitrogen containing cyclic polyamines and products thereof |
| EP1613613B1 (en) * | 2003-04-11 | 2021-06-02 | Genzyme Corporation | Cxcr4 chemokine receptor binding compounds |
| AU2004232361A1 (en) * | 2003-04-22 | 2004-11-04 | Anormed Inc. | Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| US7501518B2 (en) * | 2003-04-22 | 2009-03-10 | Genzyme Corporation | Methods of making 2,6-diaryl piperidine derivatives |
| EP1708703A4 (en) * | 2003-12-11 | 2008-04-09 | Anormed Inc | CHEMOKIN RECEPTOR BINDING COMPOUNDS |
| CN1930127B (zh) * | 2004-03-15 | 2012-11-21 | 阿诺麦德股份有限公司 | 用于合成cxcr4拮抗剂的方法 |
| JP2008509928A (ja) * | 2004-08-13 | 2008-04-03 | アノーメド インコーポレイテッド | 前駆／幹細胞を動員するためのケモカインの組み合わせ |
| US7825088B2 (en) * | 2005-04-25 | 2010-11-02 | The Cbr Institute For Biomedical Research, Inc. | Methods for the treatment of multiple myeloma |
-
2007
- 2007-08-02 AU AU2007281090A patent/AU2007281090A1/en not_active Abandoned
- 2007-08-02 US US12/375,987 patent/US20100003224A1/en not_active Abandoned
- 2007-08-02 BR BRPI0714799-6A patent/BRPI0714799A2/pt not_active Application Discontinuation
- 2007-08-02 AR ARP070103423A patent/AR063470A1/es not_active Application Discontinuation
- 2007-08-02 WO PCT/US2007/075064 patent/WO2008017025A2/en not_active Ceased
- 2007-08-02 CN CNA200780028588XA patent/CN101495115A/zh active Pending
- 2007-08-02 EP EP07813695A patent/EP2068868A2/en not_active Withdrawn
- 2007-08-02 CA CA002659463A patent/CA2659463A1/en not_active Abandoned
- 2007-08-02 JP JP2009523051A patent/JP2009545620A/ja not_active Withdrawn
- 2007-08-02 MX MX2009001272A patent/MX2009001272A/es unknown
- 2007-08-02 RU RU2009107030/15A patent/RU2009107030A/ru not_active Application Discontinuation
-
2009
- 2009-01-15 IL IL196556A patent/IL196556A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009545620A5 (https=) | ||
| JP2010507567A5 (https=) | ||
| RU2009108289A (ru) | Комбинированная терапия | |
| RU2009107030A (ru) | Комбинированная терапия | |
| Pusic et al. | Update on clinical experience with AMD3100, an SDF-1/CXCL12–CXCR4 inhibitor, in mobilization of hematopoietic stem and progenitor cells | |
| Bessard et al. | High antitumor activity of RLI, an interleukin-15 (IL-15)–IL-15 receptor α fusion protein, in metastatic melanoma and colorectal cancer | |
| WO2021050953A8 (en) | Compositions and methods for the delivery of therapeutic biologics for treatment of disease | |
| NZ707377A (en) | Combination therapy methods for treating proliferative diseases | |
| JP2016508134A5 (https=) | ||
| MX358491B (es) | Una composicion farmacéutica para tratar cáncer, que comprende un conjugado de interferón alfa. | |
| WO2005117954A3 (en) | Compositions and methods for treatment of neovascular diseases | |
| JP2012526850A5 (https=) | ||
| MX2009007830A (es) | Inhibidor de rechazo cronico. | |
| MX418886B (es) | Derivado de pirimidina que inhibe el crecimiento de celulas cancerosas y uso medicinal del mismo | |
| JP2012532624A5 (https=) | ||
| EP4470615A3 (en) | Small rna medicament for prevention and treatment of inflammation-related diseases and combination thereof | |
| Damon et al. | Mobilization of hematopoietic stem cells into the peripheral blood | |
| JP2017527551A5 (https=) | ||
| JP2013540734A5 (https=) | ||
| CN101920015A (zh) | 一种治疗癌症的药物组合物 | |
| WO2005009217A3 (en) | Diagnosis of pre-cancerous conditions using pcdgf agents | |
| AR079000A1 (es) | Terapia anticancerosa dirigida a celulas madre cancerosas resistentes a las drogas | |
| JP2016501208A5 (https=) | ||
| JPWO2020022507A5 (https=) | ||
| US20160113966A1 (en) | Composition and methods of culture supernatant of khyg-1 cells |